RALP Registration Form (new registration)

Similar documents
LP registration. e icccucclocó&ucccoc[sccoccfcgcceccucocuclc

Prostate Cancer Dashboard

S Crouzet, O Rouvière, JY Chapelon, F Mege, X martin, A Gelet

Case Discussions: Prostate Cancer

Department of Urology, Cochin hospital Paris Descartes University

Prostatectomy as salvage therapy. Cases. Paul Cathcart - Guy s & St Thomas NHS Trust, London

Diagnosis and management of prostate cancer in the

EORTC radiation Oncology Group Intergroup collaboration with RTOG EORTC 1331-ROG; RTOG 0924

New research in prostate brachytherapy

Clinical Management Guideline for Planning and Treatment. The process to be followed when a course of chemotherapy is required to treat:

When to worry, when to test?

da Vinci Prostatectomy My Greek personal experience

10th anniversary of 1st validated CaPspecific

Index. urologic.theclinics.com. Note: Page numbers of article titles are in boldface type.

Causes of Raised PSA A very large prostate Gland Infection of urine or Prostate Gland Possibility of prostate Cancer

Patient's surname/family name. Patient's first names. Date of birth. Responsible health professional. Job title. NHS number (or other identifier)

CLINICAL WORKSHOP IMAGE-GUIDED HDR BRACHYTHERAPY OF PROSTATE CANCER

2011 PROSTATE BRACHYTHERAPY STUDY

Prostate Cancer Incidence

AFTER DIAGNOSIS: PROSTATE CANCER Understanding Your Treatment Options

Prostate Cancer UK Best Practice Pathway: ACTIVE SURVEILLANCE

PSA is rising: What to do? After curative intended radiotherapy: More local options?

Prostate Case Scenario 1

Guidelines for the Management of Prostate Cancer West Midlands Expert Advisory Group for Urological Cancer

18-Oct-16. Take home messages. An update for GPs on modern radiation therapy & hormones for prostate cancer. Session plan

PROSTATE CANCER STRATIFIED FOLLOW UP. Hilary Baker Lead CNS for Uro-oncology MSc, BSc, RGN.

PROSTATIC EMBOLIZATION FOR BENIGN HYPERPLASIA

Hormone therapy works best when combined with radiation for locally advanced prostate cancer

GUIDELINES ON PROSTATE CANCER

FISTULA CARE. FISTULA TREATMENT COMPLICATIONS: Reporting Guidelines. Updated 12/12/12

Radiation Therapy for Prostate Cancer. Resident Dept of Urology General Surgery Grand Round November 24, 2008

Measuring the value of healthcare activities. Susan Rollason, Director of Finance and Strategy

Prostate Cancer UK s Best Practice Pathway

Definition Prostate cancer

Radical prostatectomy for Malignant Tumor

Prostate Cancer Case Study 1. Medical Student Case-Based Learning

Outcomes of Radical Prostatectomy in Thai Men with Prostate Cancer

3.1 Investigations for Patients Presenting with Haematuria Table 1

ADENOCARCINOMA OF THE PROSTATE

THE UROLOGY GROUP

APPENDIX I (10/4/06) (11/14/06) (04/27/07) (5/15/08) RTOG 0521

Comparative Analysis Research of Robotic Assisted Laparoscopic Prostatectomy

A schematic of the rectal probe in contact with the prostate is show in this diagram.

Date Modified: May 29, Clinical Quality Measures for PQRS

BIOCHEMICAL RECURRENCE POST RADICAL PROSTATECTOMY

Prostate cancer. Treatments Side effects and management in the community setting

Prostate MRI for local staging and surgical planning in prostate cancer

da Vinci Prostatectomy

BRACHYTHERAPY FOR PROSTATE CANCER. Dr Brandon Nguyen MBBS(Hons), FRANZCR Radiation Oncologist, The Canberra Hospital

INTERNATIONAL JOURNAL OF ONCOLOGY 46: , 2015

Case Scenario 1. 4/19/13 Bone Scan: No scintigraphic findings to suggest skeletal metastases.

The Royal Marsden. Prostate case study. Presented by Mr Alan Thompson Consultant Urological Surgeon

External Beam Radiation Therapy for Low/Intermediate Risk Prostate Cancer

16:30-18:30 WS #67: Urology Forum - Prostate Cancer, Stones, Renal Tumours, Voiding Dysfunction (120 minutes, not repeated) -

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER

Prostate Cancer in comparison to Radiotherapy alone:

Mini-Invasive Treatment in Urological Diseases Dott. Alberto Saita Responsabile Endourologia Istituto Clinico Humanitas - Rozzano

11/21/13 CEA: 1.7 WNL

South East Scotland Cancer Network Prostate Cancer Management Protocol.

Date Modified: March 31, Clinical Quality Measures for PQRS

Linac Based SBRT for Low-intermediate Risk Prostate Cancer in 5 Fractions: Preliminary Report of a Phase II Study with FFF Delivery

Anterior resection syndrome following sphincterpreserving resection in the UK population

Guidelines for the Shared Care of Patients on hormonal therapy for Prostate Cancer

RADICAL CYSTECTOMY. Solutions for minimally invasive urologic surgery

Laparoscopic Surgery. The Da Vinci Robot. Limits of Laparoscopy. What Robotics Offers. Robotic Urologic Surgery: A New Era in Patient Care

Does RT favor RP in long term Quality of Life? Juanita Crook MD FRCPC Professor of Radiation Oncology University of British Columbia

PROSTATE CANCER: A Primer of Diagnosis and Treatment. Jay C. Lee, MD, FRCSC Clinical Associate Professor University of Calgary

Reliability and Validity of the Taiwan Chinese Version of the EORTC QLQ-PR25 in Assessing Quality of Life of Prostate Cancer Patients

Index. urologic.theclinics.com. Note: Page numbers of article titles are in boldface type.

Chapter 18: Glossary

General information about prostate cancer

Bladder Cancer Guidelines

RADICAL CYSTECTOMY. Solutions for minimally invasive urologic surgery

Radical Prostatectomy: Management of the Primary From Localized to Oligometasta:c Disease

Percentage of patients who underwent endoscopic procedures following SWL

Prostate Cancer: Low Dose Rate (Seed) Brachytherapy. Information for patients, families and friends

Radical Perineal Prostatectomy and Simultaneous Extended Pelvic Lymph Node Dissection via the Same Incision

Applications of Quality of Life Outcomes in Three Recent NCIC CTG Trials: What Every New Clinician-Investigator Wants to Know

5. Localised prostate cancer

Potency after unilateral nerve sparing surgery: a report on functional and oncological results of unilateral nerve sparing surgery

Partial Removal of the Kidney

Degarelix Subcutaneous Injection (Firmagon ) Treatment Guideline

Procedure Specific Information Sheet Open Radical Prostatectomy

PSA nadir post LDR Brachytherapy and early Salvage Therapy. Dr Duncan McLaren UK & Ireland Users Group Meeting 2016

THE HISTORY AND EVOLUTION OF PROSTATE CANCER DIAGNOSIS AND TREATMENT BY: DR. ANDREW GROLLMAN ALBUQUERQUE UROLOGY ASSOCIATES

S1.04 PRINCIPAL CLINICIAN G1.01 COMMENTS S2.01 SPECIMEN LABELLED AS G2.01 *SPECIMEN DIMENSIONS (PROSTATE) S2.03 *SEMINAL VESICLES

MATERIALS AND METHODS

Prostate cancer staging and datasets: The Nitty-Gritty. What determines our pathological reports? 06/07/2018. Dan Berney Maastricht 2018

GUIDELINEs ON PROSTATE CANCER

Quality ID #250 (NQF 1853): Radical Prostatectomy Pathology Reporting National Quality Strategy Domain: Effective Clinical Care

A phase III trial of prostate alone vs. pelvic lymph node IMRT with or

MODULE 8: PROSTATE CANCER: SCREENING & MANAGEMENT

Robotics, Laparoscopy & Endosurgery

State-of-the-art: vision on the future. Urology

S1.04 Principal clinician. G1.01 Comments. G2.01 *Specimen dimensions (prostate) S2.02 *Seminal vesicles

Benign Prostatic Hyperplasia (BPH)

20 Prostate Cancer Dan Ash

Open clinical uro-oncology trials in Canada George Rodrigues, MD, Mary J. Mackenzie, MD, Eric Winquist, MD

Transcription:

RALP Registration Form (new registration) RALP registration form new registration v2.0 1

RALP registration form new registration All fields are required, except those marked with an asterisk (*) Variables with a and written in italic are multi-select variables; hence multiple answers can be selected. Variables with a O are single select variables, hence only one answer can be chosen. Patient data: National number (INSZ/NISS): Name: Date of birth: Mutuality: First name: Zipcode: Country: Incidence date: Primary site: Hospital Data: Accession number declaration agreement (RIZIV/INAMI number of the hospital): MOC registration: O Yes Past history registration: Previous urological condition: O Yes TURP (BN) Urethral stenosis Urinary stones Urinary infections Unknown Previous medical treatment for urological disease: O Yes 5-alfa-reductase inhibitors (dutasteride-finasteride) Unknown Food supplement for prostate cancer prevention: O Yes Family history for prostate cancer Family history for prostate cancer (first degree relative): O Yes Date at diagnosis*: Age at diagnosis*: year RALP registration form new registration v2.0 2/7

Diagnosis: Clinical stage (UICC TNM) Summary clinical stage: ct: cn: cm: Tumor localisation: O right O left O bilateral O unknown basis mid apex diffuse unknown Initial PSA: Value: ng/ml PSA at biopsy: Value: ng/ml Prostate biopsy: Number of biopsy cores: Number of positive cores: Details for individual core*: Left*: Core L1 Right*: Core R1 Core L2 Core R2 Core L3 Core R3 Core L4 Core R4 Core L5 Core R5 Core L6 Core R6 RALP registration form new registration v2.0 3/7

Urogenital function before treatment: Urinary function - ICIQ score : Sexual function IIEF score: Quality of life (at least one questionnaire must be filled out): QLQ-C30 score Global Health Status/QoL Global health status/qol (revised) : /100 Functional scales Physical functioning: /100 Role functioning: /100 Emotional functioning: /100 Cognitive functioning: /100 Social functioning: /100 Symptoms scales/items Fatigue: /100 Nausea and vomiting: /100 Pain: /100 Dyspnoea: /100 Insomnia: /100 Appetite loss: /100 Constipation: /100 Diarrhoea: /100 Financial difficulties: /100 EORTC PR25 score Urinary symptoms: /100 Incontinence aid: /100 Bowel symptoms: /100 Treatment related symptoms: /100 Sexual active: /100 Sexual functioning: /100 Operative data entry form: Hospitalisation number *: Date of hospitalisation: Date of surgery: Type of surgery: O laparoscopic O open O RALP RALP registration form new registration v2.0 4/7

If option RALP is selected, following variables must be filled out: Details of RALP surgery: Nerve sparing: O Yes O bilateral O unilateral right O unilateral left O unknown Lymphadenectomy: O Yes O limited O extended O unknown Blood loss : ml Intra-operative complications: O Yes* Major bleeding Origin: Rectal injury Intestinal perforation Major bladder injury Ureteral injury Nerve injury Conversion Medical reasons Malfunctioning robot Specify: Disposables used (please enter number of units used): Large needle driver Hot shears Maryland bipolar forceps Prograsp forceps Number of units*: Post-operative data: Post-operative death: O Yes Date of death: Cause of death: RALP registration form new registration v2.0 5/7

Early post-operative morbidity: O Yes Late major bleeding Transfusions*: Major urinary leakage Prolonged lymphorrea Ureteral obstruction Nerve injury / neuropraxia Compartment syndrome Rhabdomyolysis Oliguria/anuria Reintervention Reason*: units Discharge date: Deep veneus thrombosis Pulmonary embolism Pathological data: Summary ptnm stage (UICC TNM): pt: pn: pm: Details of pathological report: Gleason score Dominant pattern: + Secondary pattern*: + ptnm stage T: O x O 0 O 1 O 2a O 2b O 2c O 3a O 3b O 4 % tumor volume/total volume*: % N: O x O 0 O 1 Number of positive nodes / total nodes*:../ M: O x O 1 R: O 0 O positive Positive margins location*: Positive margins - Length *: mm RALP registration form new registration v2.0 6/7

Adjuvant treatment Radiotherapy: O Yes Total dose: Number of fractions: Start date: End date*: Gy Hormonal therapy: O Yes O LHRH-agonist Specify * : O LHRH antagonist Specify * : O Anti-androgen Specify * : O Total androgen blockade Specify *: Start date: End date*: RALP registration form new registration v2.0 7/7